Impax Laboratories Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
101,259.00
57,353.00
38,997.00
472,031.00
469,287.00
Depreciation, Depletion & Amortization
36,006.00
34,026.00
68,637.00
88,348.00
109,449.00
Other Funds
749.00
3,317.00
141,464.00
589.00
4,231.00
Funds from Operations
160,985.00
109,048.00
142,112.00
77,030.00
95,337.00
Changes in Working Capital
11,045.00
76,231.00
70,186.00
2,433.00
11,115.00
Net Operating Cash Flow
149,940.00
32,817.00
71,926.00
74,597.00
84,222.00
Capital Expenditures
44,785.00
42,913.00
31,049.00
52,902.00
26,799.00
Sale of Fixed Assets & Businesses
-
-
59,546.00
1,360.00
9,111.00
Purchase/Sale of Investments
71,106.00
29,312.00
200,064.00
-
-
Net Investing Cash Flow
115,891.00
16,601.00
467,537.00
627,092.00
9,680.00
Issuance/Reduction of Debt, Net
-
-
563,059.00
383,133.00
70,818.00
Net Financing Cash Flow
8,962.00
14,414.00
521,387.00
391,783.00
73,670.00
Net Change in Cash
42,450.00
30,261.00
125,478.00
160,218.00
1,645.00
Free Cash Flow
117,155.00
2,904.00
46,727.00
25,195.00
57,473.00
Deferred Taxes & Investment Tax Credit
21,132.00
11,810.00
29,558.00
127,405.00
74,873.00
Net Assets from Acquisitions
-
-
691,348.00
585,800.00
121.00
Other Sources
-
-
-
15,000.00
12,879.00
Change in Capital Stock
8,213.00
11,097.00
99,792.00
9,239.00
1,379.00
Exchange Rate Effect
561.00
369.00
298.00
494.00
773.00
Other Uses
-
3,000.00
4,750.00
4,750.00
4,750.00
About Impax Laboratories
View Profile
